Federation des caisses Desjardins du Quebec’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-50
Closed -$18 2326
2020
Q1
$18 Hold
50
﹤0.01% 2202
2019
Q4
$20 Hold
50
﹤0.01% 2296
2019
Q3
$94 Hold
50
﹤0.01% 2247
2019
Q2
$104 Hold
50
﹤0.01% 2229
2019
Q1
$152 Hold
50
﹤0.01% 2039
2018
Q4
$117 Hold
50
﹤0.01% 2046
2018
Q3
$197 Hold
50
﹤0.01% 2100
2018
Q2
$184 Hold
50
﹤0.01% 2122
2018
Q1
$116 Hold
50
﹤0.01% 2124
2017
Q4
$76 Hold
50
﹤0.01% 2115
2017
Q3
$105 Hold
50
﹤0.01% 2061
2017
Q2
$221 Sell
50
-4,000
-99% -$14.5K ﹤0.01% 2113
2017
Q1
$12.2K Buy
+4,050
New +$11.9K ﹤0.01% 1390

Federation des caisses Desjardins du Quebec's CORV Position: Q2 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 50 shares — an estimated $18 sold.

Federation des caisses Desjardins du Quebec first reported a position in CORV in Q1 2017 and held it in 13 quarters. The position peaked at $12.2K in Q1 2017. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

  • Federation des caisses Desjardins du Quebec reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 50 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $18.
  • Federation des caisses Desjardins du Quebec first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2017 and held it in 13 quarters.
  • Federation des caisses Desjardins du Quebec's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $12.2K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2020, filed 30 Aug 2024.